CD163 and neoplasm: Our data also show that patients with high densities of suppressor FoxP3+ or CD163+ cells in their tumor center or the invasive margin, albeit with high numbers of CD8+ cells, had trends for shorter OS compared to those who displayed low FoxP3+ or CD163+ cell frequencies (Figure 4).